Advocacy Messages

Excerpt of an op-ed by columnist George F. Will, published in The Washington Post.

’€œThe capacity to blunder slightly is the real marvel of DNA. Without this special attribute, we would still be anaerobic bacteria and there would be no music.’€

Excerpt of an article published by The Salt Lake Tribune on sequestration’€™s impact to research institutions in Utah.

Op-ed by The Honorable John Edward Porter, Research!America Chair and former U.S. Representative (1980 ’€“ 2001) published in CNN.

Excerpt of an article published by the South Bend Tribune on the devastating effects of mandatory federal budget cuts to university researchers, especially at the University of Notre Dame and Indiana University School of Medicine-South Bend.

Dear Research Advocate:

By Tyler Wiechman

Wiechman currently works in the cardiovascular specialty of a privately owned pharmaceutical company working with specialists and hospitals in the Central Pennsylvania Region.  He withdrew from a PhD in biomedical sciences from the Penn State University Hershey College of Medicine and received his BS in Psychology from the University of Delaware in 2011. He has worked for three different labs focusing on Neurological/Psychological health and behavior. 

John Eng, MD, was recently named as the latest winner of the Golden Goose Awards. Eng is the second winner announced in 2013, and others will be named in the coming weeks. The Golden Goose Award was created last year to celebrate researchers whose seemingly odd or obscure federally funded research turned out to have a significant, positive impact on society.

Dear Research Advocate:

The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word!

An excerpt of an op-ed by Dr. Jeffrey Vacirca, chief executive and managing partner of North Shore Hematology/Oncology Associates published in Newsday.

Current FOSEP leaders: Renee Agatsuma, Cyan James, Bish Paul, Abigail G. Schindler, PhD, Corey Snelson, PhD, Christopher Terai. (James and Schindler are the main authors)

Pages

Subscribe to RSS - Advocacy Messages